Has Monika Benner received payments from drug or device companies?

Yes. Drug and device makers reported $14,175 in general payments to Monika Benner across 638 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Monika Benner did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Monika Benner come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Monika Benner

Nurse Practitioner · Mokena, ILNPI 1871081711

Payments from drug & device makers

$14,175in general payments, 2019–2025

Across 638 payments — averaging $22.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$3K
AstraZeneca$2K
Lilly USA, LLC$684
Merck$575
Pfizer$529
Johnson & Johnson$513
plus $7K from 54 others

What the payments were for

Food & beverage$11,46881%
Education$1,52711%
Other$1,1808%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	95	$2,545
AstraZeneca(2 entities)	80	$2,010
Lilly USA, LLC	24	$684
Merck	32	$575
Pfizer	31	$529
Johnson & Johnson(2 entities)	27	$513
AbbVie	21	$483
Astellas Pharma US Inc	24	$460
Incyte Corporation	20	$445
Daiichi Sankyo Inc.	23	$439
Amgen	25	$421
Regeneron Healthcare Solutions, Inc.	32	$410
Takeda Pharmaceuticals U.S.A., Inc.	13	$392
E.r. Squibb & Sons, L.L.C.	17	$304
Pharmacyclics LLC, An Abbvie Company	16	$295
GSK	10	$243
Rigel Pharmaceuticals, Inc.	6	$213
Array Biopharma Inc	11	$208
Sanofi-aventis U.S. LLC	2	$200
Seagen Inc.	9	$197
ADC Therapeutics America, Inc.	4	$179
Sanofi	8	$160
Bristol Myers Squibb	9	$155
Gilead(2 entities)	9	$152
Genentech USA, Inc.	8	$147
EMD Serono, Inc.	7	$132
Eisai Inc.	6	$123
Bayer	5	$102
G1 Therapeutics, Inc.	5	$99
Beigene USA, Inc.	4	$91
Agios Pharmaceuticals, Inc.	4	$86
Jazz Pharmaceuticals Inc.	3	$77
Tersera Therapeutics LLC	2	$69
Springworks Therapeutics, Inc.	2	$57
Taiho Oncology, Inc.	3	$57
Beone Medicines USA, Inc.	2	$56
AVEO Pharmaceuticals, Inc.	2	$55
Ipsen Biopharmaceuticals, Inc	2	$53
Tempus AI, Inc	2	$53
Sumitomo Pharma America, Inc.	2	$46
Blueprint Medicines Corporation	2	$46
Morphosys, US Inc.	2	$44
Karyopharm Therapeutics Inc.	2	$43
Mirati Therapeutics, Inc.	2	$42
Servier Pharmaceuticals LLC	2	$41
Puma Biotechnology, Inc.	2	$41
Exelixis Inc.	2	$40
Boehringer Ingelheim	1	$38
Sobi, Inc	2	$37
Myovant Sciences Inc.	2	$36
Geron Corporation	1	$34
Amneal Pharmaceuticals LLC	1	$27
Syndax Pharmaceuticals, Inc.	1	$26
Blue Earth Diagnostics	1	$23
Recordati_rare_diseases_inc.	1	$21
Azurity Pharmaceuticals, Inc.	1	$20
Deciphera Pharmaceuticals Inc.	1	$19
GE HealthCare	1	$18
Tolmar Pharmaceuticals, Inc.	1	$18
Progenics Pharmaceuticals, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,175 in reported general payments places this provider in the 95th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VerzenioAbemaciclib	18	$259,646
EliquisApixaban	64	$48,563
Letrozole	48	$888
Anastrozole	43	$633
Dexamethasone	59	$611
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	35	$516
Duloxetine Hcl	27	$361
Hydrocortisone	12	$230
Prochlorperazine Maleate	14	$160
Ondansetron Hcl	17	$123
Acyclovir	20	$122
Allopurinol	13	$110
Prednisone	24	$95
Methylprednisolone	11	$74

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Lilly USA, LLCVerzenio	$684	$259,64618 claims
PfizerEliquis	$529	$48,56364 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,869 nurse practitioner providers in Illinois.

Other nurse practitioner in Mokena

Erika VuckoChicago$417K
Deepa VallikatWest Dundee$332K
Maria MalotoNaperville$135K
Valerie LaroyOak Lawn$112K
Jennifer LiebChampaign$109K
Tanya MungerRockford$106K
Kristy LukeChicago$77K
Yvonna OldakerFlossmoor$74K
Heather PiercePekin$72K
Dara McKinleyEvanston$66K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →